Notably lower T1 relaxation times, or how brain signals can weaken over time, may point to the presence of gadolinium in the brains of patients who’ve had more than one contrast-enhanced MRI exam, according to research published online Jan. 1 in Radiology.

Overall cancer deaths in the United States have steadily declined by 27 percent over the past quarter century, according to a new review from the American Cancer Society (ACS).

The findings suggest the evaluation of molecular biomarkers for Alzheimer’s disease should be adjusted for race, as African American patients were found to have lower levels of tau—a key biomarker used to identify the disease, according to research published online Jan. 7 in JAMA Neurology.

A team of Dutch researchers has developed a real-time hybrid fluoroscopic and nuclear imaging detector that may aid interventional radiology (IR) procedures such as radioembolization, according to authors of a Jan. 8 study published in Radiology.

Carestream has been awarded a multimillion-dollar healthcare IT contract for Veterans Affairs hospitals in the Pacific Northwest region, which includes Washington, Oregon, Idaho, Alaska and parts of Montana.

It may be time for diagnostic radiologists to begin thinking differently. That is according to a viewpoint article published Jan. 7 in the Journal of the American Medical Association, which argued the specialty must act as gatekeepers to combat wasted imaging.

With a recently awarded $3.2 million R01 grant from the National Institute of Neurological Disorders and Stroke (NINDS), researchers at the University of Cincinnati (UC) in Ohio plan to study how neuroimaging can help pinpoint risk factors of stroke recurrence, according to a recent university press release.

Using less than 1,000 imaging cases, researchers from Massachusetts General Hospital (MGH) in Boston were able to train an artificial intelligence (AI) algorithm to detect intracranial hemorrhage (ICH) and classify its five subtypes on unenhanced head CT scans, according to research published in the journal Nature Biomedical Engineering.

Radiotherapy combined with chemotherapy resulted in better five-year survival in patients with early-stage pediatric Hodgkin lymphoma (HL) than chemotherapy alone, reported authors of a Jan. 3 study published in JAMA Oncology.

A one-of-a-kind trial is underway testing the GE180 radioactive tracer in humans to potentially better understand the root causes of Alzheimer’s and Parkinson’s disease, the Las Vegas Review-Journal reported.